BMO Capital Markets Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $800.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price cut by BMO Capital Markets from $865.00 to $800.00 in a research note released on Wednesday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. REGN has been the subject of several other reports. JPMorgan Chase & Co. lowered their price […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price cut by BMO Capital Markets from $865.00 to $800.00 in a research note released on Wednesday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. REGN has been the subject of several other reports. JPMorgan Chase & Co. lowered their price […]
